Bayer Polymers to discontinue Cobalt-polybutadiene (CoBR) production in Marl
Reason for decision: drastic drop in demand for CoBR
Bayer Polymers, a division of Bayer AG, is planning to discontinue the production of Cobalt-polybutadiene (CoBR) at its subsidiary Bayer Buna GmbH in Marl in the first half of 2004. The reason for this decision is primarily the accelerating drop in demand for this rubber product. The CoBR facility has a total capacity of 45,000 metric tons. Some 75 employees will be affected. The company has started an information and consultation process with the works council and in the coming weeks will be working on finding individual solutions for those involved. Bayer Buna GmbH currently employs around 240 people in Marl. The production of EPDM rubber which also takes place in Marl is unaffected.
BR from Marl serves as a general-purpose rubber in tires and, in particular, as a plastics modifier for the manufacture of High Impact Polystyrene (HIPS), which is used in packaging materials and a variety of other applications. Owing to increasing substitution of CoBR by Lithium-polybutadiene (LiBR) in the HIPS application, production volumes have fallen drastically. "Closing the facility is therefore an absolute necessity in view of our strategy to improve profitability. Given the structural changes in the market, we see no possibility of continuing CoBR production in Marl," said Dr. Joachim Grub, Head of BR / Butyl Global Operations at Bayer Polymers.
Bayer Polymers will concentrate its remaining polybutadiene production at its sites in Orange (Texas, USA), Port Jérôme (France) and Dormagen (Germany).
Through a business acquisition in southern Germany, Bayer MaterialScience has expanded its position on the future-oriented market for composite materials. The company on Monday concluded the takeover of Thermoplast Composite GmbH (TCG) in Langenfeld, near Nuremberg, a technology leader spec ... more
The Supervisory Board of Bayer AG agreed to the proposal made by the Board of Management of Bayer AG to appoint Dr. Richard Pott (61) to the Supervisory Board of Bayer MaterialScience AG effective March 26, 2015. It is intended that Dr. Pott should be elected as the new Chairman of the Supe ... more
Bayer had a very successful year in 2014, both operationally and strategically. The company set new records for sales and for EBITDA before special items. “Contributing to this in particular was the continuing growth momentum in our Life Science businesses, and especially the pleasing devel ... more
Bayer Technology Services is an integral technology partner of the chemical and pharmaceutical industry. More than 2,300 highly qualified engineers and scientists worldwide back up our technological competence for the entire life cycle of processes and plants: from product and process devel ... more
Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more